Clinical trial
A Double-Blind, Randomized, Multicenter, Parallel Group Study to Establish Dose-Response, Safety, and Efficacy of Zonegran (Zonisamide) as Monotherapy in Patients With Newly Diagnosed Epilepsy
NCT00056576 is registered in ClinicalTrials.gov with Eisai Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Double-Blind, Randomized, Multicenter, Parallel Group Study to Establish Dose-Response, Safety, and Efficacy of Zonegran (Zonisamide) as Monotherapy in Patients With Newly Diagnosed Epilepsy
- Lead sponsor
- Eisai Inc.
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- February 28, 2002
- Completion date
- October 31, 2004
- Enrollment
- 165
- Sites
- 35
Conditions
As the registry lists them; a condition with its own page is linked.